Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Smith

Showing results (521-530 of 618) with videos related to

Pageof 62
Sort By:
Acta Crystallographica. Section D, Biological Crystallography|March 23, 2013
Structure, recombinant expression and mutagenesis studies of the catalase with oxidase activity from Scytalidium thermophilumYonca Yuzugullu, Chi H Trinh, Mark A Smith, et al.
Neurobiology of Disease|December 26, 2009
Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer diseaseAkihiko Nunomura, Toshio Tamaoki, Koich Tanaka, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|February 20, 2008
Redox active iron accumulation in aceruloplasminemiaLuis F Gonzalez-Cuyar, George Perry, Hiroaki Miyajima, et al.
Neurobiology of Aging|July 20, 2010
AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activationMichela Guglielmotto, Manuela Aragno, Elena Tamagno, et al.
F1000 Medicine Reports|October 16, 2010
Treatment advances in Alzheimer's disease based on the oxidative stress modelAvi L Friedlich, Raj K Rolston, Xiongwei Zhu, et al.
Neuroscience Letters|June 8, 2002
Presenilin 1 overexpressions in Chinese hamster ovary (CHO) cells decreases the phosphorylation of retinoblastoma protein: relevance for neurodegenerationMaría I Prat, Ana M Adamo, Silvia A González, et al.
Journal of Pineal Research|June 21, 2002
The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptorsMiguel A Pappolla, Marcia J Simovich, Tara Bryant-Thomas, et al.
Journal of Cellular and Molecular Medicine|March 19, 2009
Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulationMark E Obrenovich, Ludis A Morales, Celia J Cobb, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2009
Leptin: a novel therapeutic strategy for Alzheimer's diseaseNikolaos Tezapsidis, Jane M Johnston, Mark A Smith, et al.
Neurobiology of Disease|April 13, 2010
LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's diseaseChen Yao, Rabih El Khoury, Wen Wang, et al.
Pageof 62

Showing results (521-530 of 618) with videos related to

Sort By:
Pageof 62
Acta Crystallographica. Section D, Biological Crystallography|March 23, 2013
Structure, recombinant expression and mutagenesis studies of the catalase with oxidase activity from Scytalidium thermophilumYonca Yuzugullu, Chi H Trinh, Mark A Smith, et al.
Neurobiology of Disease|December 26, 2009
Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer diseaseAkihiko Nunomura, Toshio Tamaoki, Koich Tanaka, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|February 20, 2008
Redox active iron accumulation in aceruloplasminemiaLuis F Gonzalez-Cuyar, George Perry, Hiroaki Miyajima, et al.
Neurobiology of Aging|July 20, 2010
AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activationMichela Guglielmotto, Manuela Aragno, Elena Tamagno, et al.
F1000 Medicine Reports|October 16, 2010
Treatment advances in Alzheimer's disease based on the oxidative stress modelAvi L Friedlich, Raj K Rolston, Xiongwei Zhu, et al.
Neuroscience Letters|June 8, 2002
Presenilin 1 overexpressions in Chinese hamster ovary (CHO) cells decreases the phosphorylation of retinoblastoma protein: relevance for neurodegenerationMaría I Prat, Ana M Adamo, Silvia A González, et al.
Journal of Pineal Research|June 21, 2002
The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptorsMiguel A Pappolla, Marcia J Simovich, Tara Bryant-Thomas, et al.
Journal of Cellular and Molecular Medicine|March 19, 2009
Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulationMark E Obrenovich, Ludis A Morales, Celia J Cobb, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2009
Leptin: a novel therapeutic strategy for Alzheimer's diseaseNikolaos Tezapsidis, Jane M Johnston, Mark A Smith, et al.
Neurobiology of Disease|April 13, 2010
LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's diseaseChen Yao, Rabih El Khoury, Wen Wang, et al.
Pageof 62